DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,022 | +185.4% | 169,609 | +231.8% | 1.84% | -8.7% |
| Q2 2023 | $12,270 | -11.2% | 51,123 | -6.8% | 2.01% | -22.7% |
| Q1 2023 | $13,819 | -27.2% | 54,828 | -23.3% | 2.60% | -20.0% |
| Q4 2022 | $18,970 | -99.9% | 71,471 | -9.2% | 3.25% | -7.7% |
| Q3 2022 | $20,328,000 | +1.8% | 78,703 | -0.1% | 3.52% | +4.8% |
| Q2 2022 | $19,965,000 | -13.8% | 78,753 | -0.2% | 3.36% | -0.2% |
| Q1 2022 | $23,150,000 | -10.1% | 78,923 | +0.8% | 3.37% | -18.0% |
| Q4 2021 | $25,758,000 | +6.4% | 78,289 | -1.6% | 4.11% | +1.9% |
| Q3 2021 | $24,215,000 | +13.2% | 79,539 | -0.2% | 4.03% | +11.5% |
| Q2 2021 | $21,385,000 | +110.5% | 79,689 | +76.5% | 3.62% | +90.6% |
| Q1 2021 | $10,160,000 | +1.3% | 45,139 | 0.0% | 1.90% | -6.2% |
| Q4 2020 | $10,027,000 | +3.2% | 45,139 | 0.0% | 2.02% | -10.4% |
| Q3 2020 | $9,720,000 | +21.6% | 45,139 | -0.1% | 2.26% | +9.0% |
| Q2 2020 | $7,991,000 | +27.8% | 45,192 | 0.0% | 2.07% | +4.5% |
| Q1 2020 | $6,255,000 | -10.4% | 45,192 | -0.6% | 1.98% | +15.8% |
| Q4 2019 | $6,978,000 | +5.9% | 45,464 | -0.3% | 1.71% | -6.5% |
| Q3 2019 | $6,587,000 | +0.5% | 45,604 | -0.6% | 1.83% | -1.4% |
| Q2 2019 | $6,557,000 | +8.0% | 45,879 | -0.3% | 1.86% | +1.0% |
| Q1 2019 | $6,073,000 | +27.4% | 45,999 | -0.5% | 1.84% | +7.5% |
| Q4 2018 | $4,768,000 | -5.1% | 46,239 | -0.0% | 1.71% | +23.2% |
| Q3 2018 | $5,025,000 | +10.1% | 46,245 | -0.0% | 1.39% | -3.0% |
| Q2 2018 | $4,565,000 | +0.8% | 46,265 | 0.0% | 1.43% | -5.2% |
| Q1 2018 | $4,530,000 | +4.9% | 46,265 | -0.5% | 1.51% | +0.7% |
| Q4 2017 | $4,318,000 | -6.2% | 46,515 | -13.3% | 1.50% | -4.5% |
| Q3 2017 | $4,601,000 | +1.1% | 53,635 | -0.6% | 1.57% | +6.7% |
| Q2 2017 | $4,552,000 | -5.2% | 53,935 | -3.9% | 1.47% | -6.0% |
| Q1 2017 | $4,800,000 | +2.7% | 56,125 | -6.6% | 1.56% | -2.2% |
| Q4 2016 | $4,676,000 | +4.1% | 60,076 | +4.8% | 1.60% | -0.1% |
| Q3 2016 | $4,493,000 | -22.7% | 57,315 | -0.3% | 1.60% | -26.9% |
| Q2 2016 | $5,809,000 | +6.5% | 57,515 | -0.0% | 2.19% | -9.9% |
| Q1 2016 | $5,457,000 | +2.2% | 57,525 | +0.1% | 2.43% | +5.6% |
| Q4 2015 | $5,340,000 | +9.0% | 57,491 | 0.0% | 2.30% | +12.5% |
| Q3 2015 | $4,899,000 | -0.4% | 57,491 | +0.0% | 2.05% | +27.7% |
| Q2 2015 | $4,920,000 | +0.4% | 57,481 | -0.4% | 1.60% | -10.0% |
| Q1 2015 | $4,901,000 | -1.3% | 57,721 | -0.4% | 1.78% | -4.7% |
| Q4 2014 | $4,968,000 | +12.4% | 57,964 | -0.4% | 1.87% | +30.7% |
| Q3 2014 | $4,421,000 | -2.7% | 58,184 | +0.8% | 1.43% | -2.5% |
| Q2 2014 | $4,542,000 | +5.2% | 57,694 | +0.3% | 1.47% | -10.7% |
| Q1 2014 | $4,316,000 | -3.0% | 57,544 | -0.2% | 1.64% | +7.7% |
| Q4 2013 | $4,450,000 | +12.1% | 57,644 | +0.6% | 1.52% | +5.7% |
| Q3 2013 | $3,971,000 | +7.7% | 57,279 | -1.6% | 1.44% | +5.3% |
| Q2 2013 | $3,686,000 | – | 58,229 | – | 1.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |